BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Treatment
84 results:

  • 1. liver transplantation for advanced-stage primary hepatic yolk sac tumor: A case report and literature review.
    Liu GH; Qiu MK; Wang Y; Zhang TT; Wang LJ; Guan WB; Ou JM; Chen LT
    Medicine (Baltimore); 2023 Dec; 102(50):e35821. PubMed ID: 38115376
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel c-Met/trk inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation.
    An B; Nie W; Hu J; Fan Y; Nie H; Wang M; Zhao Y; Yao H; Ren Y; Zhang C; Wei M; Li W; Liu J; Yang C; Zhang Y; Li X; Tian G
    Cell Death Dis; 2023 Nov; 14(11):728. PubMed ID: 37945598
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [
    Günther T; Holzleitner N; Viering O; Beck R; Wienand G; Dierks A; Pfob CH; Bundschuh RA; Kircher M; Lapa C; Wester HJ
    J Nucl Med; 2024 Jan; 65(1):33-39. PubMed ID: 37945383
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.
    Němčíková P; Brunerová L
    Vnitr Lek; 2023; 69(5):312-315. PubMed ID: 37827829
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunosuppressive CD10
    Meng Y; Ye F; Nie P; Zhao Q; An L; Wang W; Qu S; Shen Z; Cao Z; Zhang X; Jiao S; Wu D; Zhou Z; Wei L
    J Hepatol; 2023 Dec; 79(6):1435-1449. PubMed ID: 37689322
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression and prognostic impact of NTF3 and trkC in hepatocellular carcinoma.
    Wang H; Zhong C; Qi L; Fang X; Yuan Y
    Scand J Gastroenterol; 2023; 58(11):1309-1316. PubMed ID: 37272057
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Head-to-Head Comparison of [
    Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
    Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
    [No Abstract]    [Full Text] [Related]  

  • 8. A Two-Step Diagnostic Approach for Ntrk Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas.
    Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
    Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tropomyosin receptor kinase protein expression in Thai cholangiocarcinoma: Clinicopathological correlation, expression pattern, and prognosis.
    Leepisuth P; Watcharadetwittaya S; Sa-Ngiamwibool P
    Ann Diagn Pathol; 2022 Oct; 60():151996. PubMed ID: 35753289
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Novel Therapeutics and treatment Strategies for Medullary Thyroid cancer.
    Walgama E; Busaidy N; Zafereo M
    Endocrinol Metab Clin North Am; 2022 Jun; 51(2):379-389. PubMed ID: 35662447
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prospective study on the clinical relevance of
    Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
    Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Functional imaging in thyroid cancer patients with metastases and therapeutic implications.
    Schlumberger M; Garcia C; Hadoux J; Klain M; Lamartina L
    Presse Med; 2022 Jun; 51(2):104113. PubMed ID: 35131318
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
    Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
    Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metastatic Medullary Thyroid cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
    Hayes AR; Crawford A; Al Riyami K; Tang C; Bomanji J; Baldeweg SE; Wild D; Morganstein D; Harry A; Grozinsky-Glasberg S; Oleinikov K; Khoo B; Caplin ME; Nicolas GP; Grossman AB
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4903-e4916. PubMed ID: 34379772
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer.
    Kukulska A; Krajewska J; Kołosza Z; Grządziel A; Gajek M; Paliczka-Cieślik E; Syguła D; Ficek K; Kluczewska-Gałka A; Jarząb B
    BMC Endocr Disord; 2021 Aug; 21(1):160. PubMed ID: 34372848
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Interventional Radiology Approaches for liver Metastases from Thyroid cancer: A Case Series and Overview of the Literature.
    Nervo A; Ragni A; Retta F; Calandri M; Gazzera C; Gallo M; Piovesan A; Arvat E
    J Gastrointest Cancer; 2021 Sep; 52(3):823-832. PubMed ID: 33999355
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ABCB1 and ABCG2 Restrict Brain and Testis Accumulation and, Alongside CYP3A, Limit Oral Availability of the Novel trk Inhibitor Selitrectinib.
    Li W; Sparidans RW; Martins MLF; El-Lari M; Lebre MC; van Tellingen O; Beijnen JH; Schinkel AH
    Mol Cancer Ther; 2021 Jun; 20(6):1173-1182. PubMed ID: 33785654
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid.
    Van't Erve I; Rovers KP; Constantinides A; Bolhuis K; Wassenaar EC; Lurvink RJ; Huysentruyt CJ; Snaebjornsson P; Boerma D; van den Broek D; Buffart TE; Lahaye MJ; Aalbers AG; Kok NF; Meijer GA; Punt CJ; Kranenburg O; de Hingh IH; Fijneman RJ
    J Pathol Clin Res; 2021 May; 7(3):203-208. PubMed ID: 33635598
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Breast metastasis from medullary carcinoma of thyroid: A case report with literature view.
    Mukhtar R; Hussain M; Mukhtar MA; Ali SM
    J Pak Med Assoc; 2020 Nov; 70(11):2051-2053. PubMed ID: 33341859
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population.
    Pu X; Zhu L; Li F; Zheng J; Wu H; Fu Y; Chen J; Qi L
    Pathol Res Pract; 2020 Sep; 216(9):153116. PubMed ID: 32825971
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.